Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion-Reference-Cited by-同舟云学术

Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion

Published:2014-12-23 Issue:1 Volume:4 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Warita Katsuhiko,Warita Tomoko,Beckwitt Colin H.,Schurdak Mark E.,Vazquez Alexei,Wells Alan,Oltvai Zoltán N.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep07593.pdf

Reference38 articles.

1. Issa, N. T., Byers, S. W. & Dakshanamurthy, S. Drug repurposing: translational pharmacology, chemistry, computers and the clinic. Curr. Top. Med. Chem. 13, 2328–2336 (2013).

2. Stenvang, J. et al. Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development. Front. Oncol. 3, 313, 10.3389/fonc.2013.00313 (2013).

3. Farwell, W. R. et al. The association between statins and cancer incidence in a veterans population. J. Natl. Cancer Inst. 100, 134–139, 10.1093/jnci/djm286 (2008).

4. Nielsen, S. F., Nordestgaard, B. G. & Bojesen, S. E. Statin use and reduced cancer-related mortality. N. Engl. J. Med. 367, 1792–1802, 10.1056/NEJMoa1201735 (2012).

5. Ginestier, C. et al. Mevalonate metabolism regulates basal breast cancer stem cells and is a potential therapeutic target. Stem Cell 30, 1327–1337, 10.1002/stem.1122 (2012).

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Additional statin treatment enhances the efficacy of HER2 blockade and improves prognosis in Rac1-high/HER2-positive breast cancer;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-12

2. Spectroscopic diagnosis and metabolite characterization of cisplatin resistance regulated by FDFT1 in bladder cancer tissue;Applied Radiation and Isotopes;2024-08

3. PLGA and PDMS-based in situ forming implants loaded with rosuvastatin and copper-selenium nanoparticles: a promising dual-effect formulation with augmented antimicrobial and cytotoxic activity in breast cancer cells;Frontiers in Pharmacology;2024-06-04

4. A drug repurposing approach of Atorvastatin calcium for its antiproliferative activity for effective treatment of breast cancer: In vitro and in vivo assessment;International Journal of Pharmaceutics: X;2024-06

5. Exploiting the metabolic vulnerability of circulating tumour cells;Trends in Cancer;2024-06